| abstract |
The present invention provides a dual-drug combination for Mycobacterium smegmatis, the double-drug combination is meropenem and dicloxacillin sodium, which has significant inhibitory activity against Mycobacterium smegmatis, Therefore, the double-drug combination provided by the present invention can be used to prepare a combined drug against mycobacteria, and is expected to become a potential drug against mycobacterial infection. |